Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
Both fibroblast activation protein (FAP)-targeted imaging and somatostatin receptors (SSTR)-targeted imaging were the promising imaging modalities for the diagnosis of primary and metastatic nasopharyngeal carcinoma (NPC). This prospective study is going to investigate to compare the diagnostic efficacy of 68Ga-FAPI and 68Ga-DOTATATE in detecting primary and metastatic NPC lesions, thereby obtaining a more accurate examination method of NPC.
Sponsor:
First Affiliated Hospital of Fujian Medical University
Phase:
Phase 1/2
Contacts:
Weibing Miao, MDmiaoweibing@126.com
86-0591-87981618
jieling zheng775304265@qq.com
86-599-87981619
Government Study Link:
NCT05990998 - Click here to see study onClinicalTrials.gov
Help us improve your experience